152 related articles for article (PubMed ID: 24740228)
1. Circulating cell-free DNA in cancer.
Pinzani P; Salvianti F; Orlando C; Pazzagli M
Methods Mol Biol; 2014; 1160():133-45. PubMed ID: 24740228
[TBL] [Abstract][Full Text] [Related]
2. Application of circulating tumor DNA in prospective clinical oncology trials - standardization of preanalytical conditions.
van Dessel LF; Beije N; Helmijr JC; Vitale SR; Kraan J; Look MP; de Wit R; Sleijfer S; Jansen MP; Martens JW; Lolkema MP
Mol Oncol; 2017 Mar; 11(3):295-304. PubMed ID: 28164427
[TBL] [Abstract][Full Text] [Related]
3. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.
Benesova L; Belsanova B; Suchanek S; Kopeckova M; Minarikova P; Lipska L; Levy M; Visokai V; Zavoral M; Minarik M
Anal Biochem; 2013 Feb; 433(2):227-34. PubMed ID: 22750103
[TBL] [Abstract][Full Text] [Related]
4. Analysis of methylated circulating DNA in cancer patients' blood.
Sunami E; Vu AT; Nguyen SL; Hoon DS
Methods Mol Biol; 2009; 507():349-56. PubMed ID: 18987826
[TBL] [Abstract][Full Text] [Related]
5. Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.
Medina Diaz I; Nocon A; Mehnert DH; Fredebohm J; Diehl F; Holtrup F
PLoS One; 2016; 11(11):e0166354. PubMed ID: 27832189
[TBL] [Abstract][Full Text] [Related]
6. Methods for isolation and genetic analysis of circulating tumor DNA in patient plasma.
Kawaguchi T; Holland WS; Gumerlock PH
Methods Mol Med; 2003; 85():257-62. PubMed ID: 12710213
[No Abstract] [Full Text] [Related]
7. Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.
Jung K; Fleischhacker M; Rabien A
Clin Chim Acta; 2010 Nov; 411(21-22):1611-24. PubMed ID: 20688053
[TBL] [Abstract][Full Text] [Related]
8. A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR.
Cavallone L; Aldamry M; Lafleur J; Lan C; Gonzalez Ginestet P; Alirezaie N; Ferrario C; Aguilar-Mahecha A; Basik M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):909-916. PubMed ID: 30824523
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum.
Xue X; Teare MD; Holen I; Zhu YM; Woll PJ
Clin Chim Acta; 2009 Jun; 404(2):100-4. PubMed ID: 19281804
[TBL] [Abstract][Full Text] [Related]
10. Allele specific Taqman-based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients.
Pinzani P; Salvianti F; Cascella R; Massi D; De Giorgi V; Pazzagli M; Orlando C
Clin Chim Acta; 2010 Sep; 411(17-18):1319-24. PubMed ID: 20576522
[TBL] [Abstract][Full Text] [Related]
11. Cell-free DNA concentration and integrity as a screening tool for cancer.
Zaher ER; Anwar MM; Kohail HM; El-Zoghby SM; Abo-El-Eneen MS
Indian J Cancer; 2013; 50(3):175-83. PubMed ID: 24061455
[TBL] [Abstract][Full Text] [Related]
12. Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients.
Agostini M; Enzo MV; Bedin C; Belardinelli V; Goldin E; Del Bianco P; Maschietto E; D'Angelo E; Izzi L; Saccani A; Zavagno G; Nitti D
Cancer Biomark; 2012; 11(2-3):89-98. PubMed ID: 23011155
[TBL] [Abstract][Full Text] [Related]
13. Collection of cell-free DNA for genomic analysis of solid tumors in a clinical laboratory setting.
Raymond CK; Hernandez J; Karr R; Hill K; Li M
PLoS One; 2017; 12(4):e0176241. PubMed ID: 28448587
[TBL] [Abstract][Full Text] [Related]
14. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer.
Isobe K; Hata Y; Kobayashi K; Hirota N; Sato K; Sano G; Sugino K; Sakamoto S; Takai Y; Shibuya K; Takagi K; Homma S
Anticancer Res; 2012 Aug; 32(8):3339-44. PubMed ID: 22843912
[TBL] [Abstract][Full Text] [Related]
16. Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.
Kamat AA; Sood AK; Dang D; Gershenson DM; Simpson JL; Bischoff FZ
Ann N Y Acad Sci; 2006 Sep; 1075():230-4. PubMed ID: 17108216
[TBL] [Abstract][Full Text] [Related]
17. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?
Anker P; Mulcahy H; Stroun M
Int J Cancer; 2003 Jan; 103(2):149-52. PubMed ID: 12455027
[No Abstract] [Full Text] [Related]
18. Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.
Marzese DM; Hirose H; Hoon DS
Expert Rev Mol Diagn; 2013 Nov; 13(8):827-44. PubMed ID: 24127721
[TBL] [Abstract][Full Text] [Related]
19. Brain tumor mutations detected in cerebral spinal fluid.
Pan W; Gu W; Nagpal S; Gephart MH; Quake SR
Clin Chem; 2015 Mar; 61(3):514-22. PubMed ID: 25605683
[TBL] [Abstract][Full Text] [Related]
20. Quantification of circulating DNA in the plasma and serum of cancer patients.
Taback B; O'Day SJ; Hoon DS
Ann N Y Acad Sci; 2004 Jun; 1022():17-24. PubMed ID: 15251934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
